| Financial Year |
March 31 2023 |
| Monetary Funds |
440,577,049.37 |
| Held-for-trading Financial Assets |
1,139,112,013.75 |
| Notes Receivable |
9,640,483.10 |
| Accounts Receivable |
198,050,376.25 |
| Advances to Suppliers |
20,118,239.60 |
| Other Receivables |
15,477,101.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
161,497,466.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,730,740.04 |
| Total Current Assets |
2,004,363,138.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
60,046,746.40 |
| Investment Properties |
15,447,309.74 |
| Fixed Assetes |
313,390,415.98 |
| Under-construction Projects |
46,977,357.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,261,693.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,766,958.17 |
| Deferred Income Tax Assets |
10,234,289.58 |
| Other Non-Current Assets |
38,852,203.30 |
| Sub-Total of Non-Current Assets |
572,081,008.13 |
| Total Assets |
2,576,444,146.55 |
| Short-Term Loans |
232,927,016.72 |
| Trading Financial liabilities |
67,440.00 |
| Notes Payable |
34,881,047.52 |
| Accounts Payable |
142,095,425.96 |
| Accounts Received In Advance |
8,950.00 |
| Employee Compensation Payable |
16,647,205.62 |
| Taxes Payable |
5,815,052.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,144,173.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
92,593,342.99 |
| Other Current Liabilities |
9,178,380.33 |
| Sub-Total of Current Liabilities |
582,841,911.46 |
| Long-term Loans |
86,315,186.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,345,297.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
108,986,649.57 |
| Total Liabilities |
691,828,561.03 |
| Paid-In Capital(Or Share Stock) |
305,181,620.00 |
| Capital Surplus |
1,033,424,065.65 |
| Surplus Reserve |
72,493,368.08 |
| LESS:Treasury Stock |
149,947,001.82 |
| Undistributed Profits |
618,242,607.35 |
| Minority Stockholder's Interest |
5,256,859.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,879,358,725.95 |
| Owner's Equity（Stockholder's Equity） |
1,884,615,585.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,576,444,146.55 |
